× |
|
Gluten-Related Disorder and Lactose Intolerance Concomitant With Avoidant/Restrictive Food Intake Disorder PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Staff Morale and Well-Being During the COVID-19 Pandemic PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Olanzapine-Divalproex Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed Episodes: A Double-Blind, Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
× |
                                   |
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Risks of Suicide and Poisoning Among Elderly Patients Prescribed Selective Serotonin Reuptake Inhibitors: A Retrospective Cohort Study PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study) PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Empirical Examination of a Proposed Refinement to DSM-IV Posttraumatic Stress Disorder Symptom Criteria Using the National Comorbidity Survey Replication Data PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Stressors Occurring in Psychiatry Residents Working in Psychiatric Hospitals During the COVID-19 Pandemic PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Prevalence of Psychiatric Comorbidities in Patients With Neurofibromatosis PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Less Is More in Antidepressant Clinical Trials: A Meta-Analysis of the Effect of Visit Frequency on Treatment Response and Dropout PDF |
$40.00 |
|
$40.00 |
× |
                                   |
A Man Made Manic: Levodopa-Carbidopa-Induced Mania in Traumatic Brain Injury PDF |
$40.00 |
|
$80.00 |
× |
                                   |
Psilocybin Can Diminish Depression PDF |
$40.00 |
|
$40.00 |
× |
                                   |
A Review of Fragile X Premutation Disorders: Expanding the Psychiatric Perspective PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000 PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Patient Preference for Psychological vs Pharmacologic Treatment of Psychiatric Disorders: A Meta-Analytic Review PDF |
$40.00 |
|
$40.00 |
× |
                                   |
A Post Hoc Analysis of the Effect of Nightly Administration of Eszopiclone and a Selective Serotonin Reuptake Inhibitor in Patients With Insomnia and Anxious Depression PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Differential Efficacy of Olanzapine and Lithium in Preventing Manic or Mixed Recurrence in Patients With Bipolar I Disorder Based on Number of Previous Manic or Mixed Episodes PDF |
$40.00 |
|
$40.00 |
× |
                                   |
A Moving Target: How We Define Avoidant/Restrictive Food Intake Disorder Can Double Its Prevalence PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
× |
                                   |
QTc Prolongation Secondary to Zolpidem Use PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Treating Attention-Deficit/Hyperactivity Disorder in Adults: Focus on Once-Daily Medications PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Self-Reported History of Manic/Hypomanic Switch Associated With Antidepressant Use: Data From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) PDF |
$40.00 |
|
$40.00 |
× |
                                   |
The Cost Consequences of Treatment-Resistant Depression PDF |
$40.00 |
|
$40.00 |
× |
                                   |
A 7-Week, Randomized, Double-Blind Trial of Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia PDF |
$40.00 |
|
$40.00 |
× |
                                   |
An Unmet Need: A Clozapine-Induced Myocarditis Screening Protocol PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Psychosocial Functioning, Familiality, and Psychiatric Comorbidity in Bipolar Youth With and Without Psychotic Features PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Prediabetes in Patients Treated With Antipsychotic Drugs PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Triglyceride/High-Density Lipoprotein Cholesterol Ratio: A Surrogate to Predict Insulin Resistance and Low-Density Lipoprotein Cholesterol Particle Size in Nondiabetic Patients With Schizophrenia PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Quality of Life Outcomes in Patients With Obsessive-Compulsive Disorder: Relationship to Treatment Response and Symptom Relapse PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Treatment of Premenstrual Worsening of Depression With Adjunctive Oral Contraceptive Pills: A Preliminary Report PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Luteal Phase Administration of Paroxetine for the Treatment of Premenstrual Dysphoric Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial in Canadian Women PDF |
$40.00 |
|
$40.00 |
× |
                                   |
Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis PDF |
$40.00 |
|
$40.00 |
× |
                                   |
The Continuity Between DSM-5 Obsessive-Compulsive Personality Disorder Traits and Obsessive-Compulsive Symptoms in Adolescence: An Item Response Theory Study PDF |
$40.00 |
|
$40.00 |
× |
                                   |
A Meta-Analysis of Computerized Cognitive-Behavioral Therapy for the Treatment of DSM-5 Anxiety Disorders PDF |
$40.00 |
|
$40.00 |
|